Impact of coronavirus disease 2019 on co-morbidities in HIV.
Journal
Current opinion in HIV and AIDS
ISSN: 1746-6318
Titre abrégé: Curr Opin HIV AIDS
Pays: United States
ID NLM: 101264945
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
1
2
2023
pubmed:
2
2
2023
medline:
3
2
2023
Statut:
ppublish
Résumé
This perspective paper offers some reflections on an hypothesized changing scenario of HIV comorbidities in the years to come and provides some insights on how to improve screening and management of people with HIV (PWH) in the coronavirus disease 2019 (COVID-19) era. PWH may experience a higher burden of excess disease and mortality associated with noninfectious comorbidities in the COVID-19 era. HIV care must move beyond viral-immunological success to incorporate patient-centered outcomes based on the intrinsic characteristics of the individual and its environment, assessment and screening for comorbidities, evaluation of aging and geriatric syndromes and last but not least fight stigma, ageism and inequality to access to care. COVID-19 is widening the gap between unmet needs of PWH and healthcare systems. An increasing burden of comorbidities, multimorbidity and frailty is affecting PWH which requires redesign of care delivery oriented around the diverse needs of individuals, rather than the prerequisites of providers, and must ensure health equity. In particular, any changes to care delivery must address existing disparities in access and care among PWH and fight stigma.
Identifiants
pubmed: 36722200
doi: 10.1097/COH.0000000000000785
pii: 01222929-202303000-00010
doi:
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111-115Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
WHO warns that HIV infection increases risk of severe and critical COVID-19. Available at: https://www.who.int/news/item/15-07-2021-who-warns-that-hiv-infection-increases-risk-of-severe-and-critical-covid-19 [Accessed 7 November 2022].
Chanda-Kapata P, Ntoumi F, Kapata N, et al. Tuberculosis, HIV/AIDS and malaria health services in sub-Saharan Africa – a situation analysis of the disruptions and impact of the COVID-19 pandemic. Int J Infect Dis 2022; 124: (Suppl 1): S41–S46.
Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Heal 2020; 8:e1132–e1141.
Jewell BL, Mudimu E, Stover J, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV 2020; 7:e629–e640.
Islam N, Shkolnikov VM, Acosta RJ, et al. Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ 2021; 373:n1137.
Centers for Disease Control and Prevention. Disparities in excess mortality associated with COVID-19—United States. 2020. Available at: https://www.cdc.gov/mmwr/volumes/70/wr/mm7033a2.htm [Accessed 7 November 2022].
Wadhera RK, Shen C, Gondi S, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern Med 2021; 180:159–169.
Weinberger DM, Chen J, Cohen T, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern Med 2020; 180:1336–1344.
Nowbar AN, Gitto M, Howard JP, et al. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019; 12:e005375.
Ariss RW, Minhas AMK, Issa R, et al. Demographic and regional trends of mortality in patients with acute myocardial infarction in the United States, 1999 to 2019. Am J Cardiol 2022; 164:7–13.
Yeo YH, Wang M, He X, et al. Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic. J Med Virol 2022; Sep 29. doi: 10.1002/jmv.28187. Epub ahead of print.
doi: 10.1002/jmv.28187.
Lv F, Gao X, Huang AH, et al. Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States. EClinicalMedicine 2022; 54:101671.
Dufour J-F, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut 2022; 71:2350–2362.
Zhao Y, Yeo YH, Samaan J, et al. Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19. Gut 2022; Sep 5:gutjnl-2022-328188. doi: 10.1136/gutjnl-2022-328188. Epub ahead of print.
doi: 10.1136/gutjnl-2022-328188.
Gao X, Lv F, He X, et al. Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States. J Hepatol 2023; 78:16–27.
Freedman DS, Kompaniyets L, Daymont C, et al. Weight gain among US adults during the COVID-19 pandemic through May 2021. Obesity 2022; 30:2064–2070.
Patil SS, Hiremath RN, Viswanath HK, Kadam DB. Noncommunicable disease risk factors among people living with HIV/AIDS (PLHA) – a relook during the covid-19 pandemic. J Fam Med Prim care 2022; 11:498–502.
Erlandson KM, Schrack JA, Jankowski CM, et al. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep 2014; 11:279–290.
Koroukian SM, Schiltz N, Warner DF, et al. Combinations of chronic conditions, functional limitations, and geriatric syndromes that predict health outcomes. J Gen Intern Med 2016; 31:630–637.
Greene M, Covinsky KE, Valcour V, et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr 2015; 69:161–167.
Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014; 69:833–842.
Guaraldi G, Milic J, Barbieri S, et al. Resilience and frailty in people living with HIV during the COVID era: two complementary constructs associated with health-related quality of life. J Acquir Immune Defic Syndr 2022; 89:S65–S72.
Stolz E, Mayerl H, Freidl W. The impact of COVID-19 restriction measures on loneliness among older adults in Austria. Eur J Public Health 2021; 31:44–49.
Kotwal AA, Holt-Lunstad J, Newmark RL, et al. Social isolation and loneliness among san francisco bay area older adults during the COVID-19 shelter-in-place orders. J Am Geriatr Soc 2021; 69:20–29.
Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw open 2020; 3:e2019686.
Samhkaniyan E, Mahdavi A, Mohamadpour S, Rahmani S. The effectiveness of mindfulness-based cognitive therapy on quality of life and loneliness of women with HIV. J Med Life 2015; 8:107–113.
Ezi L, Rosenstreich E, Margalit M. Loneliness, mindfulness and hope: empowering rehabilitation processes. Examines Phys Med Rehabil 2018; 110.31031/EPMR.2018.01.000517.
doi: 10.31031/EPMR.2018.01.000517
Lazarus JV, Safreed-Harmon K, Kamarulzaman A, et al. Consensus statement on the role of health systems in advancing the long-term well being of people living with HIV. Nat Commun 2021; 12:4450.
Guaraldi G, Milic J, Martinez E, et al. Human immunodeficiency virus (HIV) care models during the coronavirus disease 2019 (COVID-19) era. Clin Infect Dis 2021; 73:e1222–e1227.
Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV – the new quality of life frontier. BMC Med 2016; 14:94.
Guaraldi G, Milic J, Marcotullio S, Mussini C. A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV. J Antimicrob Chemother 2020; 75:3425–3432.
Blanco J, Morillo R, Abril V, et al. Deprescribing of nonantiretroviral therapy in HIV-infected patients. Eur J Clin Pharmacol 2020; 76:305–318.
Guaraldi G, Brogonzoli L, Marchetti G, et al . Aging and HIV: what is the gap between clinical practice and guidelines recommendations? HIV Aging 2022, New York, 13–14 Octor 2022.
Singh HK, Del Carmen T, Freeman R, et al. From one syndrome to many: incorporating geriatric consultation Into HIV care. Clin Infect Dis 2017; 65:501–506.